Nonclinical Safety Assessment of CFZ533, a Fc-Silent Anti-CD40 Antibody, in Cynomolgus Monkeys.
Saved in:
| Title: | Nonclinical Safety Assessment of CFZ533, a Fc-Silent Anti-CD40 Antibody, in Cynomolgus Monkeys. |
|---|---|
| Authors: | Ulrich P; Preclinical Safety., Flandre T; Preclinical Safety., Espie P; Pharmacokinetic Sciences., Sickert D; Pharmacokinetic Sciences., Rubic-Schneider T; Preclinical Safety., Shaw DA; Preclinical Safety., Rush JS; Autoimmunity/Transplantation/Inflammation Research, Novartis Institutes for Biomedical Research, Novartis Campus, Basel CH 4002, Switzerland. |
| Source: | Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2018 Nov 01; Vol. 166 (1), pp. 192-202. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-0929 |
|---|---|
| DOI: | 10.1093/toxsci/kfy196 |
